Blog
Notes from inside the build.
What I am seeing in pharma, AI, and the work of building things people actually use.
Pharma, AI
The Audit Trail Problem: Why Pharma's AI Deployments Will Face FDA Scrutiny by 2027
The FDA issued 40 untitled letters in a single day in September 2025. The next enforcement wave will target AI-driven decisions without audit trails. Here is why your pharma company needs to act now.
May 11 · 3 min read
AI, Pharma
Why Pharma's Best AI Bets Are Boring (And Why That's the Point)
The AI investments that will define pharma's next decade are not the flashy ones. They are the boring ones. Here is what to look for and why your CFO will not approve them.
May 10 · 3 min read
AI, Business, Pharma
How to Brief an AI Agent Like a Senior Partner: A Pharma Operator's Framework
Most pharma teams brief AI agents like search engines. The teams getting results brief them like senior associates. Here is the framework that changes the output.
May 6 · 3 min read
Pharma, AI
Why I Built Human in the Loop for Pharma
Pharma leaders make hundreds of decisions a week with no audit trail. Human in the Loop is the AI deployment model that makes pharma accountable.
Apr 29 · 3 min read
Pharma, AI
AI in Pharma Is an Architecture Decision, Not a Procurement One
Most pharma boardrooms ask which AI model to buy. The companies winning are asking which architecture to build. Here is why that matters.
Apr 8 · 3 min read
Pharma, AI
Pharma Spends $6.2B on HCP Marketing. 97% Gets Ignored.
Pharma spent 6.2 billion dollars on HCP digital marketing in 2025. 97 percent of it got ignored. Here is the data and what actually works.
Apr 1 · 3 min read
Get new posts in your inbox.
No spam. No funnel sequences. Just new writing when it ships.
Unsubscribe anytime. Your email is never sold.